Medscape | RAA Inhibitors Tied to Longer Survival With Chronic Kidney Disease Medscape NEW YORK (Reuters Health) Dec 10 - Patients with chronic kidney disease (CKD) who are taking angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) survive longer than those not on the drugs, according to a study of ... |
